Latest Breaking News On - Outer membrane protein targeting antibiotic - Page 1 : comparemela.com

Adhoc: Spexis AG: Spexis provides business update

Spexis AG / Key word(s): Miscellaneous Spexis provides business update 28-Jul-2022 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for

United statesFrance generalUnited kingdomSwitzerland generalBrigitte keller laurie doyleHernan levettStephan feldhausRaimund gabrielMc servicesNews serviceSwiss exchangeOuter membrane protein targeting antibioticInvestor relations

Spexis provides business update

Spexis AG / Key word(s): Miscellaneous Spexis provides business update 28-Jul-2022 / 07:15 CET/CEST Release of an ad hoc announcement pursua.

United statesFrance generalUnited kingdomSwitzerland generalBrigitte keller laurie doyleHernan levettStephan feldhausRaimund gabrielMc servicesOuter membrane protein targeting antibioticStrategy updateInvestor relations

Investegate |Spexis AG Announcements | Spexis AG: CARB-X milestone

Investegate announcements from Spexis AG, CARB-X milestone

United kingdomSwitzerland generalHernan levettStephan feldhausBoston university school of lawNational institute of allergyMelinda gates foundationUs department of healthUnited kingdom department of healthUniversity of zurichCare global antimicrobial resistance innovation fundBiomedical advanced researchHuman servicesBoston universityDevelopment authoritySwiss exchange

Spexis achieves first CARB-X milestone for its thanatin derivatives program and receives funding of up to USD 1 9 million to initiate lead optimization

03.03.2022 - Spexis AG / Key word(s): Agreement/Financing Spexis achieves first CARB-X milestone for its thanatin derivatives program and receives funding of up to USD 1.9 million to initiate lead optimization 03-March-2022 / 07:15 CET/CEST Release of an ad hoc . Seite 1

Switzerland generalBoston universityOuter membrane protein targeting antibioticJeff wagerChief executive officer

Spexis Achieves First CARB-X Milestone for its Thanatin Derivatives Program and Receives Funding of up to USD 1 9 Million to Initiate Lead Optimization

Spexis Achieves First CARB-X Milestone for its Thanatin Derivatives Program and Receives Funding of up to USD 1 9 Million to Initiate Lead Optimization
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United kingdomSwitzerland generalHernan levettStephan feldhausBoston university school of lawNational institute of allergyMelinda gates foundationUs department of healthUnited kingdom department of healthUniversity of zurichCare global antimicrobial resistance innovation fundBiomedical advanced researchHuman servicesBoston universityDevelopment authoritySwiss exchange